[On the use of high doses of cytostatic target therapy and autologous bone marrow transplantation in malignant lymphoreticulum diseases].
D000970:Antineoplastic Agents / Q000628:therapy*; D001853:Bone Marrow; D016026:Bone Marrow Transplantation; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D008223:Lymphoma; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D012516:Osteosarcoma / Q000628:therapy*; D012509:Sarcoma
D000970:Antineoplastic Agents
ANTINEOPLASTIC AGENTS/therapy; BONE MARROW/transplantation; HODGKIN'S DISEASE/therapy; LYMPHOSARCOMA/therapy; SARCOMA, OSTEOGENIC/therapy; SARCOMA, RETICULUM CELL/therapy